A61K 31/04
Nitro compounds
A61K31/04 (Nitro compounds) appears on 251 US grants and 453 published applications in this corpus.
Search patents in A61K- Granted patents
- 251
- Published applications
- 453
- Assignees
- 228
- Inventors
- 712
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 3 | 0 |
| 1998 | 1 | 0 |
| 1999 | 9 | 0 |
| 2000 | 5 | 0 |
| 2001 | 9 | 0 |
| 2002 | 11 | 19 |
| 2003 | 8 | 19 |
| 2004 | 11 | 19 |
| 2005 | 7 | 14 |
| 2006 | 8 | 13 |
| 2007 | 2 | 17 |
| 2008 | 5 | 30 |
| 2009 | 4 | 18 |
| 2010 | 6 | 33 |
| 2011 | 6 | 12 |
| 2012 | 11 | 9 |
| 2013 | 5 | 22 |
| 2014 | 13 | 21 |
| 2015 | 10 | 22 |
| 2016 | 10 | 20 |
| 2017 | 8 | 17 |
| 2018 | 11 | 13 |
| 2019 | 15 | 16 |
| 2020 | 9 | 22 |
| 2021 | 13 | 21 |
| 2022 | 10 | 20 |
| 2023 | 17 | 19 |
| 2024 | 9 | 21 |
| 2025 | 7 | 12 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Uses21 Apr 2026US 12,605,384 B2Intra-Cellular Therapies, Inc.
- Methods and compositions for treating neurological conditions17 Mar 2026US 12,576,042 B2
- Compositions and methods for promoting healthy neural development in an unborn baby9 Dec 2025US 12,491,217 B2The Regents of the University of California
- Acetyl-CoA carboxylase modulators21 Oct 2025US 12,448,355 B2Monsanto Technology LLC
- Organic compound (oxime) to combat chemical warfare agents21 Oct 2025US 12,448,356 B2Prepaire Labs Limited
- Organic compound (oxime) to combat chemical warfare agents1 Oct 2026US 2026/0297032 A1Prepaire Labs Limited
- Cannabinoid receptor 2 modulators16 Jul 2026US 2026/0200892 A1Hoffmann-La Roche Inc.
- Acetyl-coa carboxylase modulators23 Apr 2026US 2026/0109673 A1Monsanto Technology LLC
- Electrophilic nitroalkene benzoic acid derivates as therapeutic drugs in amyotrophic lateral sclerosis (als) and other neurodegenerative conditions5 Mar 2026US 2026/0060947 A1Institut Pasteur de Montevideo
- Novel molecules4 Dec 2025US 2025/0368595 A1XENIOPRO GmbH
Most cited
By later US patents
- Therapeutic inhibitor of vascular smooth muscle cells438US 5,981,568 ANeoRx Corporation · 1999
- Therapeutic inhibitor of vascular smooth muscle cells245US 6,171,609 B2NeoRx Corporation · 2001
- Therapeutic inhibitor of vascular smooth muscle cells179US 6,306,421 B1NeoRx Corporation · 2001
- Therapeutic inhibitor of vascular smooth muscle cells171US 6,515,009 B1NeoRx Corporation · 2003
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009